JP2024541929A5 - - Google Patents
Info
- Publication number
- JP2024541929A5 JP2024541929A5 JP2024524744A JP2024524744A JP2024541929A5 JP 2024541929 A5 JP2024541929 A5 JP 2024541929A5 JP 2024524744 A JP2024524744 A JP 2024524744A JP 2024524744 A JP2024524744 A JP 2024524744A JP 2024541929 A5 JP2024541929 A5 JP 2024541929A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- groups
- alkoxy
- alkyl
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163263108P | 2021-10-27 | 2021-10-27 | |
| US63/263,108 | 2021-10-27 | ||
| US202263268655P | 2022-02-28 | 2022-02-28 | |
| US63/268,655 | 2022-02-28 | ||
| US202263362916P | 2022-04-13 | 2022-04-13 | |
| US63/362,916 | 2022-04-13 | ||
| US202263365029P | 2022-05-20 | 2022-05-20 | |
| US63/365,029 | 2022-05-20 | ||
| US202263366101P | 2022-06-09 | 2022-06-09 | |
| US63/366,101 | 2022-06-09 | ||
| PCT/CN2022/127975 WO2023072197A1 (en) | 2021-10-27 | 2022-10-27 | Piperidinyl indole derivatives, preparation methods and medicinal uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024541929A JP2024541929A (ja) | 2024-11-13 |
| JP2024541929A5 true JP2024541929A5 (https=) | 2025-11-05 |
Family
ID=86160494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024524744A Pending JP2024541929A (ja) | 2021-10-27 | 2022-10-27 | ピペリジニルインドール誘導体、その製造方法と医薬的用途 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250243186A1 (https=) |
| EP (1) | EP4423076A4 (https=) |
| JP (1) | JP2024541929A (https=) |
| KR (1) | KR20240090506A (https=) |
| AU (1) | AU2022376760A1 (https=) |
| CA (1) | CA3236104A1 (https=) |
| MX (1) | MX2024004921A (https=) |
| TW (1) | TW202334121A (https=) |
| WO (1) | WO2023072197A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120081822A (zh) * | 2021-06-03 | 2025-06-03 | 诺瓦提斯药物公司 | 经取代的吲哚化合物及其使用方法 |
| EP4389742A4 (en) * | 2021-08-18 | 2026-01-14 | Xizang Haisco Pharmaceutical Co Ltd | HETEROAROMATIC CYCLE DERIVATIVE CONTAINING BENZO NITROGEN AND ITS USE IN MEDICINE |
| CA3247772A1 (en) * | 2022-01-24 | 2023-07-27 | Novartis Ag | Spirocyclic piperidinyl derivatives as complement factor B inhibitors and their uses |
| CN119301114A (zh) * | 2022-06-07 | 2025-01-10 | 正大天晴药业集团股份有限公司 | 双环取代的芳香羧酸类氘代化合物 |
| WO2023246677A1 (zh) * | 2022-06-20 | 2023-12-28 | 深圳信立泰药业股份有限公司 | 一种吲哚-苯基哌啶化合物及其制备方法与应用 |
| TW202423426A (zh) * | 2022-08-31 | 2024-06-16 | 美商奇努克醫療股份有限公司 | 經取代之吲哚化合物及其使用方法 |
| IL320661A (en) * | 2022-11-14 | 2025-07-01 | Novartis Pharma Ag | Solid forms of complement factor B inhibitors |
| TW202506657A (zh) * | 2023-04-27 | 2025-02-16 | 大陸商上海翰森生物醫藥科技有限公司 | 一種哌啶基吲哚化合物的鹽及其製備方法 |
| CN121889385A (zh) | 2023-07-04 | 2026-04-17 | 希塔拉生物有限公司 | 作为因子b抑制剂的2-(1h-吲哚-4-基)甲基)2h-吲唑衍生物 |
| IL325760A (en) | 2023-07-04 | 2026-03-01 | Sitala Bio Ltd | History of 2-(1H-indol-4-yl)methyl)-isoindoline as factor B inhibitors |
| WO2025008517A1 (en) | 2023-07-06 | 2025-01-09 | Sitala Bio Ltd | Indole derivatives with factor b inhibitory activity |
| WO2025008516A2 (en) | 2023-07-06 | 2025-01-09 | Sitala Bio Ltd | Novel compounds |
| CN119371402A (zh) * | 2023-07-26 | 2025-01-28 | 上海美悦生物科技发展有限公司 | 螺环烯基类或氮杂烯基类化合物及其药物组合物、制备方法和用途 |
| TW202542111A (zh) * | 2023-12-27 | 2025-11-01 | 大陸商海思科醫藥集團股份有限公司 | 一種苯基呱啶衍生物的製備方法 |
| WO2025148628A1 (zh) * | 2024-01-10 | 2025-07-17 | 河北以岭医药研究院有限公司 | 哌啶基吲哚衍生物及其制备方法和应用 |
| WO2025172535A1 (en) | 2024-02-15 | 2025-08-21 | Sitala Bio Ltd | Indole and benzimidazole compounds as factor b inhibitors |
| TW202543599A (zh) * | 2024-03-08 | 2025-11-16 | 大陸商江蘇豪森藥業集團有限公司 | 一種多元螺環化合物的晶型、其製備方法和醫藥用途 |
| WO2025185734A1 (zh) * | 2024-03-08 | 2025-09-12 | 江苏豪森药业集团有限公司 | 一种多元螺环化合物的盐及其晶型、其制备方法和医药用途 |
| WO2025252133A1 (zh) * | 2024-06-07 | 2025-12-11 | 润尔眼科药物（广州）有限公司 | 一种含吲哚基团的化合物及其用途 |
| WO2025256600A1 (zh) * | 2024-06-12 | 2025-12-18 | 润尔眼科药物（广州）有限公司 | 一种杂环化合物及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011076747A1 (en) * | 2009-12-21 | 2011-06-30 | Novartis Ag | Diaza-spiro[5.5]undecanes as orexin receptor antagonists |
| JO3425B1 (ar) * | 2013-07-15 | 2019-10-20 | Novartis Ag | مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b |
| SG11201811491YA (en) * | 2016-06-27 | 2019-01-30 | Achillion Pharmaceuticals Inc | Quinazoline and indole compounds to treat medical disorders |
| RS66635B1 (sr) * | 2017-08-31 | 2025-04-30 | Novartis Ag | Derivati piperidinil-indola za upotrebu u lečenju c3 glomerulopatije |
| WO2022028507A1 (zh) * | 2020-08-07 | 2022-02-10 | 上海美悦生物科技发展有限公司 | 一种杂环类化合物、其制备方法及用途 |
| KR20230049115A (ko) * | 2020-08-07 | 2023-04-12 | 상하이 메이유에 바이오테크 디벨롭먼트 컴퍼니 리미티드 | 보체 인자 b 억제제 및 이의 약학적 조성물, 제조 방법 및 용도 |
| CA3203320A1 (en) * | 2020-12-30 | 2022-07-07 | Xin Li | Nitrogen-containing bridged heterocyclic compound, preparation method therefor, and medical use thereof |
| AU2021414253B2 (en) * | 2020-12-30 | 2024-05-16 | Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. | Series of piperidine-substituted benzoic acid compounds, and use thereof |
| US20240217953A1 (en) * | 2021-04-16 | 2024-07-04 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Bicyclic substituted aromatic carboxylic acid compounds |
| CN120081822A (zh) * | 2021-06-03 | 2025-06-03 | 诺瓦提斯药物公司 | 经取代的吲哚化合物及其使用方法 |
| EP4389742A4 (en) * | 2021-08-18 | 2026-01-14 | Xizang Haisco Pharmaceutical Co Ltd | HETEROAROMATIC CYCLE DERIVATIVE CONTAINING BENZO NITROGEN AND ITS USE IN MEDICINE |
| CA3247772A1 (en) * | 2022-01-24 | 2023-07-27 | Novartis Ag | Spirocyclic piperidinyl derivatives as complement factor B inhibitors and their uses |
-
2022
- 2022-10-27 TW TW111140969A patent/TW202334121A/zh unknown
- 2022-10-27 WO PCT/CN2022/127975 patent/WO2023072197A1/en not_active Ceased
- 2022-10-27 AU AU2022376760A patent/AU2022376760A1/en active Pending
- 2022-10-27 JP JP2024524744A patent/JP2024541929A/ja active Pending
- 2022-10-27 CA CA3236104A patent/CA3236104A1/en active Pending
- 2022-10-27 US US18/705,084 patent/US20250243186A1/en active Pending
- 2022-10-27 KR KR1020247016505A patent/KR20240090506A/ko active Pending
- 2022-10-27 EP EP22886072.2A patent/EP4423076A4/en active Pending
- 2022-10-27 MX MX2024004921A patent/MX2024004921A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024541929A5 (https=) | ||
| JP2025504859A5 (https=) | ||
| JP2024521878A5 (https=) | ||
| JP2015515976A5 (https=) | ||
| JP2017531020A5 (https=) | ||
| WO2006105063A1 (en) | Heterobicylic inhibitors of tgfbeta | |
| JP2019522007A5 (https=) | ||
| JP2019094345A5 (https=) | ||
| JP2021535112A5 (https=) | ||
| JP2020518581A5 (https=) | ||
| HRP20250154T1 (hr) | Arilni, heteroarilni i heterociklički spojevi za liječenje poremećaja posredovanih komplementom | |
| JP2024529527A5 (https=) | ||
| JP2024517678A5 (https=) | ||
| JP2024508922A5 (https=) | ||
| JP2021521178A5 (https=) | ||
| EA025863B1 (ru) | Карбазолкарбоксамидные соединения | |
| JP2007508260A5 (https=) | ||
| JP2023544716A5 (https=) | ||
| JP2022509206A5 (https=) | ||
| JP2023520396A5 (https=) | ||
| JP2025511875A5 (https=) | ||
| JP2023534974A5 (https=) | ||
| JP2024534572A5 (https=) | ||
| JP2010514733A5 (https=) | ||
| JP2023531411A5 (https=) |